166 related articles for article (PubMed ID: 32653600)
1. Letter to the editor of radiotherapy and oncology regarding the article esposito et al: Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.
Kos S
Radiother Oncol; 2020 Dec; 153():319. PubMed ID: 32653600
[No Abstract] [Full Text] [Related]
2. Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Karam I; Voruganti IS; Poon I
Radiother Oncol; 2022 May; 170():248-249. PubMed ID: 35278592
[No Abstract] [Full Text] [Related]
3. Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Pergolizzi S; Ferini G; Parisi S
Radiother Oncol; 2022 May; 170():247. PubMed ID: 35278593
[No Abstract] [Full Text] [Related]
4. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
5. Clarifications on our review on estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods: In response to the letter of Kos.
Esposito M; Villaggi E; Bresciani S; Cilla S; Falco MD; Garibaldi C; Russo S; Talamonti C; Stasi M; Mancosu P
Radiother Oncol; 2020 Dec; 153():320-321. PubMed ID: 32663534
[No Abstract] [Full Text] [Related]
6. Letter to the editor of radiotherapy and oncology regarding of the paper "Radiotherapy enhances uptake and efficacy of
Chen J; Liu G
Radiother Oncol; 2021 Aug; 161():260. PubMed ID: 34119588
[No Abstract] [Full Text] [Related]
7. Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.
Bae SH; Kim MS; Jang WI; Kay CS; Kim W; Kim ES; Kim JH; Kim JH; Yang KM; Lee KC; Chang AR; Jo S
Jpn J Clin Oncol; 2016 Apr; 46(4):363-9. PubMed ID: 26826720
[TBL] [Abstract][Full Text] [Related]
8. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, Volume 165).
Tuscano C; Al Sayyad S; Sceni G
Radiother Oncol; 2022 Jul; 172():149-150. PubMed ID: 35413390
[No Abstract] [Full Text] [Related]
10. Stereotactic radiosurgery/stereotactic body radiation therapy-reflection on the last decade's achievements and future directions.
Knisely J; Sahgal A; Lo S; Ma L; Chang E
Ann Palliat Med; 2016 Apr; 5(2):139-44. PubMed ID: 27121742
[TBL] [Abstract][Full Text] [Related]
11. Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, volume 165).
Berger T; Noble DJ; Shelley LEA; Hopkins KI; McLaren DB; Burnet NG; Nailon WH
Radiother Oncol; 2022 Jul; 172():151-152. PubMed ID: 35398383
[No Abstract] [Full Text] [Related]
12. Update in Veterinary Radiation Oncology: Focus on Stereotactic Radiation Therapy.
Nolan MW; Gieger TL
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):933-947. PubMed ID: 31253427
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
Aneja S; Yu JB
Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
Beenakker JM; Rasch CRN
Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
[No Abstract] [Full Text] [Related]
15. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
[No Abstract] [Full Text] [Related]
16. Stereotactic radiosurgery and radiotherapy: new developments and new directions.
Corn BW; Curran WJ; Shrieve DC; Loeffler JS
Semin Oncol; 1997 Dec; 24(6):707-14. PubMed ID: 9422266
[TBL] [Abstract][Full Text] [Related]
17. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology.
Kavanagh BD
Cancer J; 2016; 22(4):245-6. PubMed ID: 27441743
[No Abstract] [Full Text] [Related]
18. [Radiation Oncology - Recent Status].
Studer G; Glanzmann C
Praxis (Bern 1994); 2021 Sep; 110(13):733-742. PubMed ID: 34583545
[TBL] [Abstract][Full Text] [Related]
19. Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer".
Franzese C; Teriaca A; De Virgilio A; Mercante G; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2022 Apr; 148(4):1003-1004. PubMed ID: 34529130
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Timmerman R; Bastasch M; Saha D; Abdulrahman R; Hittson W; Story M
Front Radiat Ther Oncol; 2011; 43():382-394. PubMed ID: 21625164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
